Cargando…
Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons
BACKGROUND: The role of hepatitis C virus (HCV) coinfection and HCV-RNA in the development of diabetes mellitus (DM) in HIV-positive persons remains unclear. METHODS: Poisson regression was used to compare incidence rates of DM (blood glucose >11.1 mmol/L, HbA1C >6.5% or >48 mmol/mol, start...
Autores principales: | Mocroft, Amanda, Lundgren, Jens D, Rockstroh, Juergen K, Aho, Inka, Wandeler, Gilles, Nielsen, Lars, Edwards, Simon, Viard, Jean-Paul, Lacombe, Karine, Fätkenheuer, Gerd, Guaraldi, Giovanni, Laguno, Montserrat, Llibre, Josep, Elinav, Hila, Flamholc, Leo, Gisinger, Martin, Paduta, Dzmitry, Khromova, Irina, Jilich, David, Rozplochowski, Blazej, Oprea, Cristiana, Peters, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772946/ https://www.ncbi.nlm.nih.gov/pubmed/33409325 http://dx.doi.org/10.1093/ofid/ofaa470 |
Ejemplares similares
-
Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection
por: Begré, Lorin, et al.
Publicado: (2022) -
HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
por: Peters, Lars, et al.
Publicado: (2014) -
Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients
por: Peters, Lars, et al.
Publicado: (2013) -
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens
por: Cozzi‐Lepri, A, et al.
Publicado: (2017) -
Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey
por: Lazarus, Jeffrey V., et al.
Publicado: (2016)